Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas H Varvel

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Molecular Pharmacology|August 24, 2004
Nordihydroguaiaretic acid does not disaggregate beta-amyloid(1-40) protofibrils but does inhibit growth arising from direct protofibril associationMelissa A Moss, Nicholas H Varvel, Michael R Nichols, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 24, 2008
Abeta oligomers induce neuronal cell cycle events in Alzheimer's diseaseNicholas H Varvel, Kiran Bhaskar, Anita R Patil, et al.
Acta Neuropathologica|November 22, 2011
The presence of Aβ seeds, and not age per se, is critical to the initiation of Aβ deposition in the brainTsuyoshi Hamaguchi, Yvonne S Eisele, Nicholas H Varvel, et al.
The Journal of Experimental Medicine|October 14, 2015
Replacement of brain-resident myeloid cells does not alter cerebral amyloid-β deposition in mouse models of Alzheimer's diseaseNicholas H Varvel, Stefan A Grathwohl, Karoline Degenhardt, et al.
The Journal of Clinical Investigation|November 13, 2009
NSAIDs prevent, but do not reverse, neuronal cell cycle reentry in a mouse model of Alzheimer diseaseNicholas H Varvel, Kiran Bhaskar, Maria Z Kounnas, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 8, 2016
Infiltrating monocytes promote brain inflammation and exacerbate neuronal damage after status epilepticusNicholas H Varvel, Jonas J Neher, Andrea Bosch, et al.
The American Journal of Pathology|September 25, 2010
CX3CR1 deficiency alters microglial activation and reduces beta-amyloid deposition in two Alzheimer's disease mouse modelsSungho Lee, Nicholas H Varvel, Megan E Konerth, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|December 9, 2020
Peripheral Myeloid Cell EP2 Activation Contributes to the Deleterious Consequences of Status EpilepticusNicholas H Varvel, Claudia Espinosa-Garcia, Sarah Hunter-Chang, et al.
Journal of Medicinal Chemistry|April 15, 2026
Novel EP2 Antagonist Attenuates Microgliosis and Memory Deficits in Pilocarpine-Induced Status Epilepticus MiceThota Ganesh, Soheila Pourkhodadad, Paola Heman-Bozadas, et al.
Neurobiology of Aging|August 11, 2010
Ibuprofen attenuates oxidative damage through NOX2 inhibition in Alzheimer's diseaseBrandy L Wilkinson, Paige E Cramer, Nicholas H Varvel, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Molecular Pharmacology|August 24, 2004
Nordihydroguaiaretic acid does not disaggregate beta-amyloid(1-40) protofibrils but does inhibit growth arising from direct protofibril associationMelissa A Moss, Nicholas H Varvel, Michael R Nichols, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 24, 2008
Abeta oligomers induce neuronal cell cycle events in Alzheimer's diseaseNicholas H Varvel, Kiran Bhaskar, Anita R Patil, et al.
Acta Neuropathologica|November 22, 2011
The presence of Aβ seeds, and not age per se, is critical to the initiation of Aβ deposition in the brainTsuyoshi Hamaguchi, Yvonne S Eisele, Nicholas H Varvel, et al.
The Journal of Experimental Medicine|October 14, 2015
Replacement of brain-resident myeloid cells does not alter cerebral amyloid-β deposition in mouse models of Alzheimer's diseaseNicholas H Varvel, Stefan A Grathwohl, Karoline Degenhardt, et al.
The Journal of Clinical Investigation|November 13, 2009
NSAIDs prevent, but do not reverse, neuronal cell cycle reentry in a mouse model of Alzheimer diseaseNicholas H Varvel, Kiran Bhaskar, Maria Z Kounnas, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 8, 2016
Infiltrating monocytes promote brain inflammation and exacerbate neuronal damage after status epilepticusNicholas H Varvel, Jonas J Neher, Andrea Bosch, et al.
The American Journal of Pathology|September 25, 2010
CX3CR1 deficiency alters microglial activation and reduces beta-amyloid deposition in two Alzheimer's disease mouse modelsSungho Lee, Nicholas H Varvel, Megan E Konerth, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|December 9, 2020
Peripheral Myeloid Cell EP2 Activation Contributes to the Deleterious Consequences of Status EpilepticusNicholas H Varvel, Claudia Espinosa-Garcia, Sarah Hunter-Chang, et al.
Journal of Medicinal Chemistry|April 15, 2026
Novel EP2 Antagonist Attenuates Microgliosis and Memory Deficits in Pilocarpine-Induced Status Epilepticus MiceThota Ganesh, Soheila Pourkhodadad, Paola Heman-Bozadas, et al.
Neurobiology of Aging|August 11, 2010
Ibuprofen attenuates oxidative damage through NOX2 inhibition in Alzheimer's diseaseBrandy L Wilkinson, Paige E Cramer, Nicholas H Varvel, et al.
Pageof 3